/HRPMF
HRPMF Stock - Herantis Pharma Oyj
Healthcare|BiotechnologyOTC
$3.51+0.00%
+$0.00 (+0.00%) • Sep 9
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.86
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HRPMF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.47 – $3.55
TARGET (TP)$4.04
STOP LOSS$3.23
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.43
52W High$3.51
52W Low$3.51
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | $-928,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-5,026,000 | $154,368 | $-7,993,000 | $-9,050,000 | $-8,072,000 |
| Net Income | $-4,939,000 | $279,840 | $-9,324,000 | $-23,576,000 | $-9,153,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.24 | $0.02 | $-0.64 | $-2.20 | $-1.18 |
Company Overview
Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HRPMFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$N/A
EPS Surprise History
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2023 | Mar 2, 2023 | — | — | — | — |
Q3 2022 | Aug 25, 2022 | — | — | — | — |
Q1 2022 | Mar 7, 2022 | — | — | — | — |
Q3 2021 | Aug 26, 2021 | — | — | — | — |
Q1 2021 | Mar 3, 2021 | — | — | — | — |
Q3 2020 | Aug 25, 2020 | — | — | — | — |
Q1 2020 | Feb 27, 2020 | — | — | — | — |
Q3 2019 | Aug 28, 2019 | — | — | — | — |
Q1 2019 | Feb 28, 2019 | — | — | — | — |
Q3 2018 | Aug 29, 2018 | — | — | — | — |
Q1 2018 | Mar 2, 2018 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about HRPMF
What is HRPMF's current stock price?
Herantis Pharma Oyj (HRPMF) is currently trading at $3.51 per share. The stock has moved +0.00% today.
What is the analyst price target for HRPMF?
No analyst price targets are currently available for this stock.
What sector is Herantis Pharma Oyj in?
Herantis Pharma Oyj operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is HRPMF's market cap?
Herantis Pharma Oyj has a market capitalization of $0.06 billion, making it a small-cap company.
Does HRPMF pay dividends?
No, Herantis Pharma Oyj does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBSTG
Biostage, Inc.
$4.03
Mkt Cap: $0.1B
DMTTF
Small Pharma Inc.
$0.11
Mkt Cap: $0.0B
EEOIF
Elegance Optical International Holdings Limited
$0.07
Mkt Cap: $0.1B
GDNSF
Goodness Growth Holdings, Inc.
$0.45
Mkt Cap: $0.1B
KDEVF
Karolinska Development AB (publ)
$0.26
Mkt Cap: $0.1B
MSSTF
Mindset Pharma Inc.
$0.54
Mkt Cap: $0.1B
NEVPF
Abliva AB (publ)
$0.03
Mkt Cap: $0.0B
ONPPF
Oncopeptides AB (publ)
$0.27
Mkt Cap: $0.1B
RLFTD
Relief Therapeutics Holding AG
$4.08
Mkt Cap: $0.0B
SYMQY
SymBio Pharmaceuticals Limited
$0.64
Mkt Cap: $0.0B
Explore stocks similar to HRPMF for comparison